NeuroActiva
Biomed Industries, Inc.™ is a biopharmaceutical company focused on developing innovative treatments for unmet needs in neurological, metabolic, and cardiovascular diseases. Utilizing AI and machine learning, Biomed is committed to the commercialization of new drug therapeutics targeting conditions such as ALS, Alzheimer's Disease, Major Depressive Disorder, Stroke, Diabetes Obesity, Liver Disease MASH, and Rett Syndrome. Their pipeline includes several drugs in various phases of clinical trials, showcasing a strong commitment to addressing significant health challenges and improving patient outcomes.
NeuroActiva
Biomed Industries, Inc.™ is a biopharmaceutical company focused on developing innovative treatments for unmet needs in neurological, metabolic, and cardiovascular diseases. Utilizing AI and machine learning, Biomed is committed to the commercialization of new drug therapeutics targeting conditions such as ALS, Alzheimer's Disease, Major Depressive Disorder, Stroke, Diabetes Obesity, Liver Disease MASH, and Rett Syndrome. Their pipeline includes several drugs in various phases of clinical trials, showcasing a strong commitment to addressing significant health challenges and improving patient outcomes.